Groundbreaking Stem Cell Procedure Reverses Woman's Type 1 Diabetes

A 25-year-old woman in China becomes insulin-independent after receiving reprogrammed stem cells derived from her own body.

The woman started producing her own insulin less than three months after the transplant and has maintained normal blood glucose levels for over a year.
Researchers used chemically induced pluripotent stem cells (CiPSCs) to create insulin-producing islet cells, which were transplanted into her abdominal muscles.
The procedure was monitored using MRI scans, allowing researchers to closely observe the transplanted cells.
This study marks the first time Type 1 diabetes has been reversed using a patient's own reprogrammed stem cells.
Experts caution that larger clinical trials are needed to confirm the treatment's long-term safety and efficacy.